Articles tagged with Autoantibodies
Researchers at Yale University found that autoantibodies in severe COVID-19 cases can attack healthy tissue and organs, leading to increased disease severity. The study also suggests that long-lived rogue antibodies may contribute to lasting medical symptoms, or long COVID cases.
Researchers used a mouse model to identify the role of autoreactive T cells against transcriptional intermediary factor 1γ (TIF1γ) in dermatomyositis. The study found that autoreactive CD8+ T cells contribute to the pathogenesis of the disease, while autoantibodies are non-pathogenic clinical markers.
Recent studies suggest that postural orthostatic tachycardia syndrome (POTS) is an autoimmune disorder characterized by elevated inflammatory markers and autoantibodies. Researchers have documented significant elevations of five inflammatory markers in patients with POTS, similar to those seen in other autoimmune disorders.
A study published in Molecular Psychiatry has identified patterns of maternal autoantibodies associated with autism spectrum disorder, allowing for early diagnosis and potential behavioral intervention. Researchers found that these biomarkers can predict the likelihood and severity of autism with high accuracy.
Researchers identified two novel genetic variants in the Siglec-10 protein that predispose individuals to polyneuropathy after gut infection. These variants impair the protein's ability to bind gangliosides, leading to autoantibody production and damage to neurons.
Research found that ginger's 6-gingerol lowers autoantibody production and helps halt disease progression in mice with antiphospholipid syndrome and lupus. The compound prevents neutrophil extracellular trap release, triggering autoantibodies and inflammation.
Researchers are using cutting-edge technology to analyze immune cell interactions in lupus patients, identifying potential targets for new therapies. The Lupus Mechanisms and Targets Award will support innovative studies aimed at improving diagnostics and treatments for the disease.
A new study identifies an autoimmune antibody as a cause of COVID-19 blood clots in up to half of patients. Researchers found that blocking or removing these antibodies may improve outcomes for severely ill patients.
Children with multiple islet autoantibodies are more likely to progress to symptomatic type 1 diabetes than those who remain positive for a single autoantibody. Detailed information about the order, timing and type of autoantibodies appearing after the first autoantibody can significantly improve prediction of which children are most l...
Two twin studies report specific mechanisms of impaired type I interferon signaling in hospitalized COVID-19 patients, associating mutations and neutralizing autoantibodies with severe respiratory symptoms. Administering specific type I IFNs to select high-risk patients may offer therapeutic benefits, especially early in the disease co...
A new study published in PLOS Medicine suggests that rheumatoid arthritis patients with and without autoantibodies have distinct conditions. Longitudinal data from 1,285 RA patients showed improved disease activity but varying long-term outcomes depending on autoantibody status.
A research group has identified a novel autoantibody as a major risk factor for recurrent pregnancy loss, with the antibody found in 52 out of 227 patients. The discovery suggests that the antibody may be connected to RPL even after ruling out other common causes.
Researchers developed a novel biosensor to diagnose and monitor autoimmune disorders, measuring autoantibody concentration and activity with high sensitivity. The tool enables the creation of new diagnostic criteria and approaches to treatment, offering improved accuracy and reliability.
The Critical Path Institute (C-Path) has received a letter of support from the European Medicines Agency (EMA) to facilitate the development and validation of pancreatic islet autoantibodies as enrichment biomarkers for type 1 diabetes clinical trials. This collaboration aims to accelerate drug development in T1D by identifying patient...
Research from Joslin Diabetes Center found that autoantibodies against heart muscle proteins are associated with increased volume of the left ventricle, reduced pumping function, and higher risk of failure. The study suggests a novel process involving the heart linked to poor glycemic control in type 1 diabetes patients.
A study by the University of Bonn has identified an autoantibody that triggers epilepsy in some patients. The autoantibody targets the protein Drebrin, disrupting nerve cell transmission and leading to inflammation and seizures.
Researchers have found that autoantibodies against the NMDA receptor can reduce symptoms of depression and anxiety when they enter the brain. The level of these autoantibodies increases with age and is higher in people subjected to chronic stress, but may also play a positive role in reducing depressive symptoms.
A study by Karolinska Institutet researchers identifies a molecular mechanism linking ALS and type 2 diabetes, where immunoglobulin G antibodies target calcium channels in pancreatic beta cells, leading to cell death. The findings suggest altered humoral immunity may be a generalized phenomenon for other neurodegenerative diseases.
Researchers validate the hypothesis that IgG autoantibodies are crucial to IgA nephropathy's pathogenic immunodeposits. The study found co-localization of IgA1 and IgG in glomerular deposits, confirming their role in disease progression.
Research suggests that autoantibodies targeting the NMDA receptor in pregnant women may cause behavioral disorders in their children. Studies have found a link between these autoantibodies and neurodevelopmental disorders such as autism, schizophrenia, and ADHD.
Researchers found that 89% of patients had elevated levels of autoantibodies against the adrenergic alpha 1 receptor, suggesting an autoimmune connection to postural orthostatic tachycardia syndrome. A simple blood test could aid in diagnosis, paving the way for easier identification and treatment.
A new WHO autoantibody reference reagent has been developed to align autoantibody analyses, improving diagnosis and treatment for patients with Systemic Lupus Erythematosus (SLE) worldwide. The reference reagent was evaluated in an international study and showed significant improvements in differences between different anti-dsDNA assays.
Researchers discovered a blood signature predicting type 1 diabetes before its onset, enabling early identification of high-risk children. The study, led by the University of Turku, could lead to disease prevention.
A University of Tsukuba-led study found that OX40-expressing follicular helper T cells control rheumatoid arthritis by promoting inflammation through autoantibody sialylation. The interaction between OX40 on T cells and OX40L on antibody-producing B cells led to reduced sialylation, increasing autoimmune inflammation.
Researchers found a link between 'leaky gut' and autoantibody production in HIV-positive patients, with high levels of Staphylococcus products in the blood. A 'leaky gut' allows bacteria to enter the bloodstream, triggering an immune response that can lead to autoimmunity.
Researchers are developing a novel detection method for autoantibodies in Lupus patients using top-down mass spectrometry. This may lead to novel biomarkers and early intervention strategies for the disease.
The TEDDY study, following nearly 9,000 children over five years, aims to identify high-risk genes and environmental factors that contribute to type 1 diabetes. Early screening and intervention may be possible through analyzing autoantibodies in newborns and tracking changes in risk factors as children age.
Researchers discover Ets1 gene's role in autoimmune disease lupus; found that faulty gene leads to Tfh2 cell expansion and autoantibody production. Blocking IL4 pathway mitigates SLE features.
Researchers identified autoantibodies against adrenocorticotropic hormone (ACTH) in aggressive male prison inmates, showing altered cortisol secretion and decreased time to attack in mice. These findings suggest potential molecular mechanisms underlying human aggression and stress response.
Researchers from Osaka University have identified an antibody that alleviates symptoms in neuromyelitis optica in rats by suppressing RGMa. The study uses a new localized animal model to investigate the correlation between inflammation and motor function disruption.
Researchers identified six novel chromosomal regions associated with type 1 diabetes, enabling the discovery of more genes that cause the disease. The study also found different genetic markers for early detection of autoantibodies in patients at risk.
A new study of children from Sweden and Finland found that the swine flu vaccine Pandemrix did not increase the risk of developing autoantibodies against insulin-producing beta cells or type 1 diabetes. In fact, vaccinated children in Finland showed a reduced risk of developing autoantibodies and type 1 diabetes.
Researchers at the University of Basel have created a treatment approach using customized synthetic glycopolymers that act as molecular sponges to neutralize disease-causing antibodies. This innovative method has potential applications for treating other antibody-mediated autoimmune diseases.
Researchers identified six people with hypertriglyceridemia whose bodies produce autoantibodies against GPIHBP1, preventing LPL from reaching capillaries. This newly discovered syndrome, dubbed the GPIHBP1 autoantibody syndrome, has life-threatening potential and may be treatable with immunosuppressive drugs.
The Critical Path Institute has launched a consortium to qualify islet autoimmunity antibodies as prognostic biomarkers for Type 1 Diabetes (T1D) research. The goal is to identify individuals at risk of disease progression and develop interventions to prevent or delay the onset of symptomatic T1D.
Scientists developed a biosensor that can detect cancer proteins in serum samples, allowing for early detection of tumors. The method is faster and more accurate than traditional methods, with a 440-fold higher sensitivity.
A new study by Johns Hopkins researchers reveals a strong link between angiotensin receptor autoantibodies and increased risk of frailty in older adults. The study suggests that common blood pressure drugs targeting the autoantibodies, called ARBs, may help protect against functional decline in some people.
Researchers from Mayo Clinic identified a new biomarker for brain and spinal cord inflammation, allowing for faster diagnosis and treatment of patients with autoimmune meningoencephalomyelitis. The biomarker, an antibody targeting glial fibrillary acidic protein, helps diagnose the disease earlier and promotes more effective therapy.
A recent study found a connection between follicular T helper cells and the development of type 1 diabetes. The cells were increased in frequency close to disease onset, particularly in children with multiple autoantibodies.
Researchers have identified a potential trigger of immune-mediated neuropathies, a chronic form of nerve disorder, as antibodies against the protein Caspr. The discovery could lead to targeted treatment for sufferers and improved diagnosis through simple blood tests.
Researchers found that patients with a rare autoimmune disorder produce antibodies that limit immune-related diseases, including type 1 diabetes. These autoantibodies target proteins such as interferons and interleukins, potentially inhibiting the development of type 1 diabetes.
Researchers found that diabetic women were three times more likely to have anti-fetal brain autoantibodies, which may be linked to increased inflammation and neurodevelopmental conditions in children. The study suggests that metabolic conditions during pregnancy may alter maternal immune tolerance to the fetus.
The Fr1da study has detected an early stage of type 1 diabetes in 105 out of 26,760 children aged two to five years. The children have not shown signs of metabolic imbalance, suggesting a potential breakthrough in preventive healthcare. Families are being offered comprehensive support and care.
Researchers at Penn State College of Medicine have discovered a potential target for treating lupus: interferon gamma. The cytokine stimulates immune cells and is involved in the formation of autoreactive B cells that produce autoantibodies, leading to inflammation and tissue damage.
Researchers identified 5 autoantibody classifiers that can distinguish lung cancer from smoker controls with high sensitivity and specificity, as well as those from benign lung nodules. These findings have the potential to improve early detection of lung cancer through companion molecular diagnostic modalities.
Recurrent Strep A infections may lead to autoimmune neuropsychiatric disorders in children through a previously unknown route. Immune cells triggered by the infection travel along odor-sensing neurons to reach the brain, causing inflammation and promoting neuroinflammation.
A blood test that detects Alzheimer's disease presence has shown promise in early detection, allowing patients to make beneficial lifestyle changes to slow or halt disease progression. This discovery provides hope for those affected by the disease, enabling them to take proactive steps before symptoms emerge.
Researchers have identified three ways to predict the development of type 1 diabetes in young children based on autoantibody presence. The presence of these autoantibodies can indicate an autoimmune reaction against the body's own insulin cells, which may be triggered by a viral infection.
A new study found that exposure to mercury, even at low levels considered safe, is associated with an increased risk of autoimmunity in women. Researchers analyzed data from the National Health and Nutrition Examination Survey and found that greater exposure to mercury was linked to a higher rate of autoantibodies, a precursor to autoi...
Researchers have identified a second protein, THSD7A, associated with membranous nephropathy, a common cause of kidney failure. This finding allows for the development of a new blood test to diagnose and monitor the disease, providing additional tools for clinicians to follow treatment response.
Researchers developed a novel fluorescence-based assay for detecting antibodies in serum samples, enabling earlier diagnosis and better disease progression tracking. The new assay is particularly useful for small sample volumes, making it suitable for studies with limited sample availability.
A study by Penn Medicine researchers found a common genetic link among patients with pemphigus vulgaris, a blistering skin disease. The researchers identified a particular gene, VH1-46, that was used by PV antibodies across all four patients, suggesting common mechanisms for developing the disease.
A worldwide study by Georgia State University found no link between baby formula consumption and diabetes-associated autoantibodies. The TRIGR study tracked children genetically predisposed to type 1 diabetes for seven years, revealing a lack of correlation between cow's milk protein and autoantibody development.
A large-scale study of over 2,100 infants found that delaying exposure to complex foreign proteins in cow's milk does not reduce the risk of developing type 1 diabetes. The study, led by Professor Mikael Knip, explored whether an early dietary modification could affect the disease process.
A study of 2,070 children found no association between hydrolyzed formulas and reduced risk of beta-cell autoimmunity in infancy. The use of hydrolyzed formulas during infancy did not reduce the incidence of diabetes-associated autoantibodies after 7 years.
Researchers found that children with prediabetes and multiple islet autoantibodies had lower vitamin D levels, which increased during summer months. Vitamin D supplementation may be recommended at an early stage to prevent deficiency.
Researchers at Stanford University developed a microarray to identify cytokines, chemokines, and other proteins targeted by SLE patients' autoantibodies. They found that patients with high levels of autoantibodies against B cell activating factor (BAFF) experienced more severe symptoms.
Researchers found that LIF levels were predictive of NPC patient response to radiation therapy, with patients having higher serum levels of LIF being resistant to treatment. LIF itself promotes NPC progression and radioresistance. Circadian clock proteins BMAL1 also regulate redox proteins preventing oxidative stress damage in neurons.
Researchers found autoantibodies in patients with primary Sjögren syndrome 18-7 years before symptoms appeared. The study's results suggest that autoantibody profiling may help identify individuals at risk of autoimmune disease years before symptom onset.
A decade-long study reveals that nearly 70% of children with multiple islet autoantibodies developed T1D within 10 years, highlighting the importance of pre-diabetes research. The study also found that progression of the disease was faster for those who showed the presence of antibodies at younger than three years old.